Professor, Lecturer and Columnist Norman Miller, Ph.D. Along With Physician and Former US Navy Officer Michael Couris, M.D. Appointed to the FreMon Scientific Board of Directors.

San Diego, California – FreMon Scientific CEO and Chief Scientific Officer, Farideh Z. Bischoff, Ph.D., along with Moni Shavit and Fred Thacher, Co-Founders are pleased to announce the appointment of and welcome Dr. Miller and Dr. Couris to the Board of Directors. FreMon Scientific manufactures the most advanced blood products warming and thawing medical and laboratory technology that is FDA cleared and AABB certified. Visit fremonscientific.com.

“We welcome both Norman and Michael,” Dr. Bischoff stated. “Dr. Miller and Dr. Couris bring exceptional strength and experience from the worlds of finance, medicine and engineering to the FreMon Scientific Board of Directors. With their guidance and direction the Company will accelerate sales growth, bring new pipeline products to market and help improve patient care and medical research programs.” 

Dr. Miller is the Hahn Chair of Real Estate Finance and Professor at the University of San Diego and lectures around the world. He is Vice President of the Homer Hoyt Foundation. He works with the FDIC and DOJ developing financial tools to support financial institutions and investors and advises funds.

Dr. Couris is a graduate of MIT in engineering and Georgetown University Medical Center. He is Board Certified in Ophthalmology and a former US Navy medical officer at the Naval Medical Center San Diego and the Naval Aerospace and Occupational Medical Institute. He practices surgery at both Scripps Mercy and Memorial hospitals and is active in numerous community boards.

Further, Dr. Bischoff said, “FreMon Scientific’s co-founders each have significant military and medical experience and know the value for rapidly and safely getting life saving plasma to patients in need. They join me in welcoming Norman and Michael.”

Dr. Bischoff received her Ph.D. at the University of Texas Health Science Center at Houston in cancer biology and her BS at Stony Brook University. She has been CEO and Chief Scientific Officer of FreMon Scientific for three years guiding the Company through FDA clearance, ISO and UL certification and AABB review. She is the author of numerous scientific papers.

Media Contact
Company Name: FreMon Scientific
Contact Person: Frederick Thacher – Co-founder, Chief Development Officer
Email: Send Email
Phone: 617-308-4405
Country: United States
Website: Fremonscientific.com